89 related articles for article (PubMed ID: 20519924)
1. [A case of complicated perioperative management of radical nephrectomy in a patient with a drug-eluting stent].
Matsumura E; Yonou H; Tasaki S; Toyosato T; Ashimine S; Machida N; Goya M; Oshiro Y; Saito S
Hinyokika Kiyo; 2010 May; 56(5):265-8. PubMed ID: 20519924
[TBL] [Abstract][Full Text] [Related]
2. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
Bhatt SH; Hauser TH
Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
[TBL] [Abstract][Full Text] [Related]
3. [Perioperative management for nephrectomy in a long-term hemodialysis patient with anticoagulants for coronary stent].
Tabuchi Y; Nosaka S; Amakata Y; Takamitsu Y; Shibata N
Masui; 1998 Jun; 47(6):720-5. PubMed ID: 9691592
[TBL] [Abstract][Full Text] [Related]
4. Patients with drug-eluting stents and management of their anticoagulant therapy in cutaneous surgery.
Chu MB; Turner RB; Kriegel DA
J Am Acad Dermatol; 2011 Mar; 64(3):553-8. PubMed ID: 21255871
[TBL] [Abstract][Full Text] [Related]
5. [A patient undergoing surgery for gastric cancer four weeks after insertion of a drug-eluting coronary stent].
Kunitake A; Ohkubo S; Mori S; Kasaba T; Takasaki M
Masui; 2008 Aug; 57(8):1005-7. PubMed ID: 18710011
[TBL] [Abstract][Full Text] [Related]
6. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
7. [Perioperative management of patients with drug-eluting coronary stents presenting for non-cardiac surgery].
Arai F; Kita T; Sasaki S
Masui; 2008 Jul; 57(7):879-85. PubMed ID: 18649644
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery stents: II. Perioperative considerations and management.
Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of the patient with a coronary stent.
Popescu WM
Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
Moussa ID; Colombo A
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
[TBL] [Abstract][Full Text] [Related]
11. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
Eisenberg MJ; Richard PR; Libersan D; Filion KB
Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
[TBL] [Abstract][Full Text] [Related]
12. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting.
Brichon PY; Boitet P; Dujon A; Mouroux J; Peillon C; Riquet M; Velly JF; Ris HB
Eur J Cardiothorac Surg; 2006 Nov; 30(5):793-6. PubMed ID: 16996274
[TBL] [Abstract][Full Text] [Related]
13. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
Yan BP; Gurvitch R; Ajani AE
Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
[TBL] [Abstract][Full Text] [Related]
14. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
Tan VP; Yan BP; Kiernan TJ; Ajani AE
Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
[TBL] [Abstract][Full Text] [Related]
15. Noncardiac surgery and bleeding after percutaneous coronary intervention.
To AC; Armstrong G; Zeng I; Webster MW
Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
17. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
[TBL] [Abstract][Full Text] [Related]
18. Late coronary stent thrombosis complicating urologic surgery.
de Korte FI; van Werkum JW; Vijverberg PL; Ten Berg JM
Eur Urol; 2008 Jul; 54(1):221-5; quiz 225. PubMed ID: 17964710
[TBL] [Abstract][Full Text] [Related]
19. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation.
Latib A; Morici N; Cosgrave J; Airoldi F; Godino C; Brambilla N; Chieffo A; Bonizzoni E; Carlino M; Bedogni F; Montorfano M; Sangiorgi GM; Briguori C; Colombo A
Am J Cardiol; 2008 Dec; 102(11):1477-81. PubMed ID: 19026299
[TBL] [Abstract][Full Text] [Related]
20. Rationale for low-molecular weight heparin in coronary stenting.
Zidar JP
Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
